Cell Culture of Glioma Specimens for in Vitro Preclinical Studies

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2009 by Albany Medical College.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Albany Medical College
ClinicalTrials.gov Identifier:
NCT01125826
First received: May 18, 2010
Last updated: June 24, 2011
Last verified: April 2009

May 18, 2010
June 24, 2011
April 2009
April 2012   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01125826 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Cell Culture of Glioma Specimens for in Vitro Preclinical Studies
Primary Cell Culture of Surgical Glioma Specimens for Invitro Preclinical Studies

The purpose of this study is to culture primary human brain tumor cells with the specific aims of:

  1. Develop primary cultures from human brain tumor surgical specimens
  2. Determine the genetic and molecular fingerprints of brain tumors that may have prognostic significance
  3. Delineate the mechanisms underlying oncogenesis of brain tumors.
  4. Perform in vitro assays with brain tumor derived primary cultures to assess the efficacy of novel therapeutic agents.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:

All subjects will be give permission for specimen storage by signing a separate permission on the informed consent. All specimens will be stored at a tissue bank for an unspecified amount of time.

Probability Sample

Patients 18 years of age or older undergoing surgical resection for gliomas.

Brain Tumor
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
50
June 2012
April 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients 18 years of age or older undergoing surgical resection for glioma

Exclusion Criteria:

  • Under 18 years of age
Both
18 Years and older
No
Contact: Yu-Hung Kuo, MD 518 262 5088 kuoy@mail.amc.edu
United States
 
NCT01125826
2536
No
Yu-Hung Kuo, MD, Neurosciences Institute, Albany Medical College
Albany Medical College
Not Provided
Not Provided
Albany Medical College
April 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP